IGMS Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own IGMS shares is 118, representing 63.81% of the company's common stock.

NUVEEN ASSET MANAGEMENT, LLC, in the last quarter, reduced its stake in IGMS by -18.21% restricting it's holding to 40.75 thousand shares of worth nearly $393.23K. JANE STREET GROUP, LLC also lessened -12.67% of the IGMS shares from its portfolio, reducing its holding to 31.12 thousand shares of worth $300.31K. PANAGORA ASSET MANAGEMENT INC also shunned IGMS shares holding by -22.97% last quarter which brought its holding to 23.32 thousand shares worth $225.03K.

As per its latest 13F filing, EXCHANGE TRADED CONCEPTS, LLC increased its stake in IGMS by 46.66% in the last quarter. The institutional holder raised its holding to 27.94 thousand shares having worth more than $269.57K. WELLINGTON MANAGEMENT GROUP LLP also added 100% more shares of IGMS to its portfolio, raising its holding to 57.19 thousand shares of worth $551.88K. SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC also increased its IGMS shares holding by 100% which brought its holding to 27.73 thousand shares worth $267.60K.

The insider with the most stakes in IGMS is Topsoe Holding A/S , 10 percent owner at the company. Additionally, IGMS stock is highly held by Green Jeremy and director Redmile Group, LLC among others.

Company executives, directors, and other insiders own 34.95% percent of IGM Biosciences, Inc.'s stock. Within the last six months, there have been 12 transaction(s) in which IGMS insiders have sold stock, totaling 17.43K shares. Insiders that have sold shares include WEBER STEVEN, DECKER LISA LYNN, and HARLER MARY BETH.

There have been 0 transaction(s) during the past 6-months in which IGM Biosciences, Inc. insiders have bought stock, totalling 0 shares

Around 1.71M IGM Biosciences, Inc. shares are held by insiders, which represents about 34.95% of IGMS stock.

IGMS 10 percent owner, Topsoe Holding A/S holds the largest portfolio of the company's shares. IGMS shares owned by Topsoe total nearly 5.04 million.

EXCHANGE TRADED CONCEPTS, LLC is the largest institutional owner in IGMS which holds 27.94 thousand shares worth $269.57K or 0.05% of the total IGMS shares outstanding followed by BRUCE & CO., INC. with ownership of 65 thousand shares representing 0.11% of the IGMS ownership. PENNANT INVESTORS, LP is the third largest stakeholder with 64.9 thousand shares or 0.11% of the ownership worth more than $626.29K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the IGMS is concerned, it is a stock which is optionable.

Number of IGMS shares short is 2.51M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 34.08M shares of IGMS are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, IGMS has 11.67M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for IGMS is 10.72.